Day: May 29, 2019

FDA Clearance of Aptima BV and Aptima CV/TV Molecular Assays Ushers in New Era of Comprehensive and Objective Diagnostic Testing for Vaginitis

--Improved accuracy in identifying bacterial vaginosis (BV), vulvovaginal candidiasis (Candida vaginitis, CV) and trichomoniasis (Trichomonas vaginalis, TV) will enable more...

To Bolster Opioid Fight, HSTpathways Hosts Focus Group with Top Ambulatory Surgery Center Industry Leaders and Former White House Deputy Director of Domestic Policy Council Lance Leggitt

Steps to Combatting the Country’s Opioid Crisis Identified: Risk Assessments, Prevention Protocols, Outcome Reporting, and Education SAN FRANCISCO--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/ASC?src=hash"...

Vesper Medical Announces $37 Million Financing with Vensana Capital and Gilde Healthcare to Complete Development of Its Duo Venous Stent System™

WAYNE, Pa.--(BUSINESS WIRE)--Vesper Medical, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced a $37...

error: Content is protected !!